Literature DB >> 24826145

6-Chloro-2-chloro-methyl-4-phenyl-quinazoline 3-oxide.

Thammarse S Yamuna1, Jerry P Jasinski2, Manpreet Kaur1, Hemmige S Yathirajan1, Maravanahalli S Siddegowda3.   

Abstract

In the title compound, C15H10Cl2N2O, the dihedral angle between the mean planes of the phenyl ring and the 10-membered quinazoline ring is 63.3 (4)°. In the crystal, pairs of weak C-H⋯O inter-actions link the mol-ecules into centrosymmetric dimers, forming R 2 (2)(10) graph-set ring motifs. In addition, weak π-π stacking inter-actions [minimum centroid-centroid separation = 3.6810 (8) Å] are observed, which contribute to the formation of a supramolecular assembly in the packing array.

Entities:  

Year:  2014        PMID: 24826145      PMCID: PMC3998526          DOI: 10.1107/S1600536814005303

Source DB:  PubMed          Journal:  Acta Crystallogr Sect E Struct Rep Online        ISSN: 1600-5368


Related literature

For general background and the pharmacological properties of quinazoline derivatives, see: Andries et al. (2005 ▶); Al-Rashood et al. (2006 ▶); Ghorab et al. (2010a ▶,b ▶,c ▶); Harris & Thorarensen (2004 ▶); Jantova et al. (2004 ▶); Rádl et al. (2000 ▶); Klepser & Klepser (1997 ▶). For related structures, see: Brown & Gainsford (1979 ▶); El-Brollosy et al. (2012 ▶); Shi et al. (2004 ▶); Suguna et al. (1982 ▶); Xie & Li (2006 ▶). For standard bond lengths, see: Allen et al. (1987 ▶).

Experimental

Crystal data

C15H10Cl2N2O M = 305.15 Monoclinic, a = 8.2030 (3) Å b = 14.3203 (5) Å c = 11.8477 (4) Å β = 105.016 (4)° V = 1344.22 (9) Å3 Z = 4 Mo Kα radiation μ = 0.48 mm−1 T = 173 K 0.22 × 0.16 × 0.08 mm

Data collection

Agilent Xcalibur (Eos, Gemini) diffractometer Absorption correction: multi-scan (CrysAlis PRO and CrysAlis RED; Agilent, 2012 ▶) T min = 0.829, T max = 1.000 17250 measured reflections 4599 independent reflections 3778 reflections with I > 2σ(I) R int = 0.033

Refinement

R[F 2 > 2σ(F 2)] = 0.038 wR(F 2) = 0.100 S = 1.03 4599 reflections 181 parameters H-atom parameters constrained Δρmax = 0.44 e Å−3 Δρmin = −0.48 e Å−3 Data collection: CrysAlis PRO (Agilent, 2012 ▶); cell refinement: CrysAlis PRO; data reduction: CrysAlis PRO; program(s) used to solve structure: SUPERFLIP (Palatinus & Chapuis, 2007 ▶); program(s) used to refine structure: SHELXL2012 (Sheldrick, 2008 ▶); molecular graphics: OLEX2 (Dolomanov et al., 2009 ▶); software used to prepare material for publication: OLEX2. Crystal structure: contains datablock(s) I. DOI: 10.1107/S1600536814005303/zs2289sup1.cif Structure factors: contains datablock(s) I. DOI: 10.1107/S1600536814005303/zs2289Isup2.hkl Click here for additional data file. Supporting information file. DOI: 10.1107/S1600536814005303/zs2289Isup3.cml CCDC reference: 990666 Additional supporting information: crystallographic information; 3D view; checkCIF report
C15H10Cl2N2OF(000) = 624
Mr = 305.15Dx = 1.508 Mg m3
Monoclinic, P21/nMo Kα radiation, λ = 0.71073 Å
a = 8.2030 (3) ÅCell parameters from 5430 reflections
b = 14.3203 (5) Åθ = 3.1–32.8°
c = 11.8477 (4) ŵ = 0.48 mm1
β = 105.016 (4)°T = 173 K
V = 1344.22 (9) Å3Irregular, colourless
Z = 40.22 × 0.16 × 0.08 mm
Agilent Xcalibur (Eos, Gemini) diffractometer4599 independent reflections
Radiation source: Enhance (Mo) X-ray Source3778 reflections with I > 2σ(I)
Graphite monochromatorRint = 0.033
Detector resolution: 16.0416 pixels mm-1θmax = 32.8°, θmin = 3.1°
ω scansh = −12→12
Absorption correction: multi-scan (CrysAlis PRO and CrysAlis RED; Agilent, 2012)k = −21→21
Tmin = 0.829, Tmax = 1.000l = −17→17
17250 measured reflections
Refinement on F2Primary atom site location: structure-invariant direct methods
Least-squares matrix: fullHydrogen site location: inferred from neighbouring sites
R[F2 > 2σ(F2)] = 0.038H-atom parameters constrained
wR(F2) = 0.100w = 1/[σ2(Fo2) + (0.0411P)2 + 0.6066P] where P = (Fo2 + 2Fc2)/3
S = 1.03(Δ/σ)max < 0.001
4599 reflectionsΔρmax = 0.44 e Å3
181 parametersΔρmin = −0.48 e Å3
0 restraints
Geometry. All esds (except the esd in the dihedral angle between two l.s. planes) are estimated using the full covariance matrix. The cell esds are taken into account individually in the estimation of esds in distances, angles and torsion angles; correlations between esds in cell parameters are only used when they are defined by crystal symmetry. An approximate (isotropic) treatment of cell esds is used for estimating esds involving l.s. planes.
xyzUiso*/Ueq
Cl10.80516 (4)0.57556 (2)0.41153 (3)0.02910 (9)
Cl21.25299 (5)0.02361 (3)0.52366 (4)0.03835 (10)
O10.70795 (12)0.42471 (7)0.59735 (8)0.0258 (2)
N10.77812 (13)0.37116 (7)0.53548 (8)0.01880 (19)
N20.80968 (14)0.34057 (8)0.34467 (9)0.0222 (2)
C10.75384 (16)0.39185 (9)0.41604 (10)0.0206 (2)
C20.90492 (15)0.26388 (9)0.38678 (10)0.0202 (2)
C30.97031 (17)0.20909 (10)0.31009 (11)0.0255 (3)
H30.94290.22340.23080.031*
C41.07367 (17)0.13503 (10)0.35109 (12)0.0269 (3)
H41.11580.09840.30030.032*
C51.11527 (16)0.11514 (9)0.47137 (12)0.0244 (2)
C61.05319 (16)0.16552 (9)0.54919 (11)0.0222 (2)
H61.08320.15070.62830.027*
C70.94247 (15)0.24056 (8)0.50668 (10)0.0188 (2)
C80.86931 (15)0.29543 (8)0.58051 (10)0.0181 (2)
C90.88618 (15)0.27188 (8)0.70445 (10)0.0193 (2)
C100.96680 (16)0.33233 (9)0.79356 (10)0.0229 (2)
H101.00800.38950.77580.027*
C110.98512 (17)0.30648 (10)0.90932 (11)0.0270 (3)
H111.04150.34580.96930.032*
C120.91999 (18)0.22262 (10)0.93578 (11)0.0282 (3)
H120.93160.20631.01340.034*
C130.83771 (18)0.16286 (10)0.84755 (12)0.0273 (3)
H130.79280.10690.86570.033*
C140.82261 (17)0.18705 (9)0.73159 (11)0.0233 (2)
H140.76990.14640.67200.028*
C150.66120 (17)0.47967 (9)0.37389 (11)0.0237 (2)
H15A0.56860.48760.40990.028*
H15B0.61510.47710.28980.028*
U11U22U33U12U13U23
Cl10.02893 (17)0.02459 (16)0.03348 (17)−0.00319 (11)0.00757 (13)0.00339 (12)
Cl20.0404 (2)0.02622 (17)0.0529 (2)0.00878 (14)0.02027 (18)0.00153 (15)
O10.0310 (5)0.0258 (5)0.0227 (4)0.0072 (4)0.0109 (4)−0.0010 (3)
N10.0198 (5)0.0202 (5)0.0164 (4)0.0000 (4)0.0047 (4)−0.0005 (3)
N20.0224 (5)0.0271 (5)0.0160 (4)−0.0036 (4)0.0032 (4)−0.0006 (4)
C10.0204 (5)0.0232 (6)0.0167 (5)−0.0026 (4)0.0021 (4)0.0017 (4)
C20.0196 (5)0.0242 (6)0.0165 (5)−0.0044 (4)0.0041 (4)−0.0027 (4)
C30.0258 (6)0.0326 (7)0.0188 (5)−0.0067 (5)0.0071 (5)−0.0074 (5)
C40.0255 (6)0.0295 (6)0.0283 (6)−0.0066 (5)0.0116 (5)−0.0119 (5)
C50.0222 (6)0.0205 (6)0.0323 (6)−0.0023 (4)0.0102 (5)−0.0048 (5)
C60.0237 (6)0.0212 (5)0.0229 (5)−0.0011 (4)0.0084 (5)−0.0002 (4)
C70.0194 (5)0.0205 (5)0.0170 (5)−0.0033 (4)0.0055 (4)−0.0018 (4)
C80.0195 (5)0.0196 (5)0.0151 (4)−0.0020 (4)0.0044 (4)−0.0003 (4)
C90.0203 (5)0.0223 (5)0.0162 (5)0.0030 (4)0.0062 (4)0.0011 (4)
C100.0226 (6)0.0269 (6)0.0190 (5)−0.0001 (5)0.0052 (4)−0.0005 (4)
C110.0247 (6)0.0378 (7)0.0176 (5)0.0051 (5)0.0042 (5)−0.0021 (5)
C120.0284 (7)0.0389 (7)0.0189 (5)0.0116 (5)0.0089 (5)0.0077 (5)
C130.0317 (7)0.0270 (6)0.0264 (6)0.0066 (5)0.0135 (5)0.0081 (5)
C140.0266 (6)0.0228 (6)0.0218 (5)0.0010 (5)0.0087 (5)0.0011 (4)
C150.0232 (6)0.0238 (6)0.0214 (5)−0.0008 (4)0.0011 (4)0.0038 (4)
Cl1—C151.7905 (13)C6—C71.4128 (17)
Cl2—C51.7366 (14)C7—C81.4194 (16)
O1—N11.2943 (13)C8—C91.4778 (15)
N1—C11.4086 (15)C9—C101.3926 (17)
N1—C81.3467 (15)C9—C141.3921 (17)
N2—C11.2901 (16)C10—H100.9300
N2—C21.3651 (17)C10—C111.3906 (17)
C1—C151.4872 (17)C11—H110.9300
C2—C31.4076 (17)C11—C121.383 (2)
C2—C71.4134 (16)C12—H120.9300
C3—H30.9300C12—C131.384 (2)
C3—C41.366 (2)C13—H130.9300
C4—H40.9300C13—C141.3909 (17)
C4—C51.4058 (19)C14—H140.9300
C5—C61.3686 (17)C15—H15A0.9700
C6—H60.9300C15—H15B0.9700
O1—N1—C1118.46 (10)N1—C8—C9118.47 (10)
O1—N1—C8122.39 (10)C7—C8—C9122.71 (10)
C8—N1—C1119.13 (10)C10—C9—C8121.01 (11)
C1—N2—C2119.02 (10)C14—C9—C8118.97 (11)
N1—C1—C15116.24 (11)C14—C9—C10120.01 (11)
N2—C1—N1123.84 (11)C9—C10—H10120.3
N2—C1—C15119.90 (11)C11—C10—C9119.40 (12)
N2—C2—C3119.36 (11)C11—C10—H10120.3
N2—C2—C7120.83 (11)C10—C11—H11119.8
C3—C2—C7119.79 (12)C12—C11—C10120.36 (13)
C2—C3—H3119.7C12—C11—H11119.8
C4—C3—C2120.56 (12)C11—C12—H12119.8
C4—C3—H3119.7C11—C12—C13120.47 (12)
C3—C4—H4120.6C13—C12—H12119.8
C3—C4—C5118.88 (12)C12—C13—H13120.2
C5—C4—H4120.6C12—C13—C14119.56 (13)
C4—C5—Cl2118.63 (10)C14—C13—H13120.2
C6—C5—Cl2118.60 (11)C9—C14—H14119.9
C6—C5—C4122.76 (12)C13—C14—C9120.18 (12)
C5—C6—H6120.7C13—C14—H14119.9
C5—C6—C7118.54 (12)Cl1—C15—H15A110.0
C7—C6—H6120.7Cl1—C15—H15B110.0
C2—C7—C8118.15 (11)C1—C15—Cl1108.56 (9)
C6—C7—C2119.38 (11)C1—C15—H15A110.0
C6—C7—C8122.46 (11)C1—C15—H15B110.0
N1—C8—C7118.80 (10)H15A—C15—H15B108.4
Cl2—C5—C6—C7179.38 (9)C3—C2—C7—C8−177.77 (11)
O1—N1—C1—N2−176.01 (11)C3—C4—C5—Cl2−177.62 (10)
O1—N1—C1—C155.43 (16)C3—C4—C5—C61.7 (2)
O1—N1—C8—C7−179.81 (11)C4—C5—C6—C70.10 (19)
O1—N1—C8—C91.37 (17)C5—C6—C7—C2−2.69 (18)
N1—C1—C15—Cl180.38 (12)C5—C6—C7—C8178.70 (11)
N1—C8—C9—C10−63.17 (16)C6—C7—C8—N1173.70 (11)
N1—C8—C9—C14117.95 (13)C6—C7—C8—C9−7.54 (18)
N2—C1—C15—Cl1−98.24 (12)C7—C2—C3—C4−1.82 (18)
N2—C2—C3—C4176.35 (12)C7—C8—C9—C10118.06 (14)
N2—C2—C7—C6−174.59 (11)C7—C8—C9—C14−60.81 (16)
N2—C2—C7—C84.09 (17)C8—N1—C1—N22.29 (18)
C1—N1—C8—C71.96 (16)C8—N1—C1—C15−176.27 (11)
C1—N1—C8—C9−176.85 (11)C8—C9—C10—C11−177.93 (12)
C1—N2—C2—C3−178.21 (12)C8—C9—C14—C13179.60 (12)
C1—N2—C2—C7−0.05 (18)C9—C10—C11—C12−1.71 (19)
C2—N2—C1—N1−3.24 (18)C10—C9—C14—C130.71 (19)
C2—N2—C1—C15175.27 (11)C10—C11—C12—C130.8 (2)
C2—C3—C4—C5−0.76 (19)C11—C12—C13—C140.8 (2)
C2—C7—C8—N1−4.93 (17)C12—C13—C14—C9−1.6 (2)
C2—C7—C8—C9173.83 (11)C14—C9—C10—C110.93 (19)
C3—C2—C7—C63.56 (17)
D—H···AD—HH···AD···AD—H···A
C15—H15A···O1i0.972.573.4199 (16)146
Table 1

Hydrogen-bond geometry (Å, °)

D—H⋯A D—HH⋯A DA D—H⋯A
C15—H15A⋯O1i 0.972.573.4199 (16)146

Symmetry code: (i) .

  8 in total

1.  A diarylquinoline drug active on the ATP synthase of Mycobacterium tuberculosis.

Authors:  Koen Andries; Peter Verhasselt; Jerome Guillemont; Hinrich W H Göhlmann; Jean-Marc Neefs; Hans Winkler; Jef Van Gestel; Philip Timmerman; Min Zhu; Ennis Lee; Peter Williams; Didier de Chaffoy; Emma Huitric; Sven Hoffner; Emmanuelle Cambau; Chantal Truffot-Pernot; Nacer Lounis; Vincent Jarlier
Journal:  Science       Date:  2004-12-09       Impact factor: 47.728

2.  A short history of SHELX.

Authors:  George M Sheldrick
Journal:  Acta Crystallogr A       Date:  2007-12-21       Impact factor: 2.290

Review 3.  Drug treatment of HIV-related opportunistic infections.

Authors:  M E Klepser; T B Klepser
Journal:  Drugs       Date:  1997-01       Impact factor: 9.546

4.  Synthesis of novel pyrrole and pyrrolo[2,3-d]pyrimidine derivatives bearing sulfonamide moiety for evaluation as anticancer and radiosensitizing agents.

Authors:  Mostafa M Ghorab; Fatma A Ragab; Helmy I Heiba; Hanan A Youssef; Marwa G El-Gazzar
Journal:  Bioorg Med Chem Lett       Date:  2010-08-07       Impact factor: 2.823

5.  Synthesis and analgesic activity of some quinazoline analogs of anpirtoline.

Authors:  S Rádl; P Hezky; J Proska; I Krejcí
Journal:  Arch Pharm (Weinheim)       Date:  2000-11       Impact factor: 3.751

Review 6.  Advances in the discovery of novel antibacterial agents during the year 2002.

Authors:  Christina R Harris; Atli Thorarensen
Journal:  Curr Med Chem       Date:  2004-08       Impact factor: 4.530

7.  Synthesis and biological activities of some novel triazoloquinazolines and triazinoquinazolines containing benzenesulfonamide moieties.

Authors:  Mostafa M Ghorab; Zienab H Ismail; Mohamed Abdalla
Journal:  Arzneimittelforschung       Date:  2010

8.  1-{[(2,3-Dihydro-1H-inden-2-yl)-oxy]meth-yl}quinazoline-2,4(1H,3H)-dione.

Authors:  Nasser R El-Brollosy; Necmi Dege; Güneş Demirtaş; Mohamed I Attia; Ali A El-Emam; Orhan Büyükgüngör
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2012-05-23
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.